Zaiken MC, Flynn R, Paz KG, et al. BET-bromodomain and EZH2 inhibitor–treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood. 2022;139(19):2983-2997.

On page 2986, in Figure 2G, in the y-axis title of the leftmost plot, “%CD38+ of lymphocytes” should read “%CD138+ of lymphocytes.” The corrected Figure 2G is shown below.

Figure 2.

JQ1 and JQ5 impair the GC reaction in murine cGVHD/BO mice. (G) Flow cytometric analysis of single-cell lung suspensions taken from transplanted mice treated with each drug (n = 5/group). (Left) Total plasma cells are CD138⁺ lymphocytes, (center) immature plasma cells are B220⁺, CD19⁺ plasma cells, and (right) mature plasma cells are B220⁻, CD19⁻ plasma cells. Results show that both drugs significantly reduced the proportion of mature plasma cells in subject lungs.

In “Materials and methods” on page 2987, an incorrect reagent is listed under “Flow cytometry.” The reagent “anti-CD38 (102718; BioLegend)” should read “anti-CD138 (142514; BioLegend).”